2-n-propylthiazolidine-4-carboxylic acid has been researched along with Shock, Cardiogenic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M; Braun-Dullaeus, RC; de Waha, S; Desch, S; Ebelt, H; Eitel, I; Empen, K; Figulla, HR; Fuernau, G; Hambrecht, R; Hausleiter, J; Hennersdorf, M; Kurowski, V; Lauer, B; Maier, SK; Minden, HH; Möllmann, H; Neumann, FJ; Olbrich, HG; Rochor, K; Schneider, S; Schuler, G; Schwarz, B; Strasser, RH; Thiele, H; Werdan, K; Zeymer, U | 1 |
1 trial(s) available for 2-n-propylthiazolidine-4-carboxylic acid and Shock, Cardiogenic
| Article | Year |
|---|---|
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Topics: Coronary Artery Bypass; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Prognosis; Prospective Studies; Research Design; Shock, Cardiogenic; Thiazoles | 2012 |